Prior to 2010, there were actually three classifications of drugs: de patente – patent or name brand version, genérico intercambiable – generic but tested to be 100% interchangeable with the name brand version, and similares -drug containing the same ingredients as the patent version but lacking the testing for bioequivalence. Many of the drugs sold by the pharmaceutical chain Farmacias Similares prior to the change fell into the third category. That’s the primary reason why some people were critical of the quality of their products.
In 2004, there was a significant reform to the health law (Ley General de Salud) requiring all of the medications sold in Mexico to pass rigorous testing for bioequivalence beginning in 2010. In layman’s terms, they were eliminating the third category. This was great news for the consumer and it greatly increased people’s trust in generic medications.
To comply with the new law, Farmacias Similares conducted testing on all of their medications at a cost of between $50,000 – $90,000 USD each. The generic medications that the chain now sells have been tested and approved for quality, dosage and bioequivalence.
The government agency that oversees the medication registry and maintains compliance is the Comisíon Federal para la Protección Contra Riesgos Sanitarios (COFEPRIS), who confirmed that all of the generic medications sold in Mexico have been thoroughly tested to ensure that they are the equivalent of the name brand version. It doesn’t matter if the medication is purchased in Farmacias Similares, Farmacias del Ahorro or Walmart, it’s going to be the same in terms of ingredients and effectiveness. The only difference will be in appearance (i.e. color, shape and packaging).
There are common and persistent misconceptions when it comes to generic drugs sold in Mexico. Both the Comisíon Federal para la Protección Contra Riesgos Sanitarios (COFEPRIS) and the Procuraduría Federal del Consumidor (PROFECO) have been working to dispel these misconceptions by educating the public through social media and other outlets. Mexico is to be commended for creating both the legislation and the governmental infrastructure necessary to ensure that people can trust the generic drugs sold in Mexico. In doing so, they’ve found a way to reduce the cost of health care for their citizens, as well as any foreigners who call Mexico home.
This article is brought to you by the Sonoran Resorts Sales Team, www.sonoranresorts.mx, Jim Ringquist, Director of Sales and Marketing. Sign up for Jim’s Monthly Newsletter: www.tinyurl.com/JimNewsletter